MannKind | Biaya Operasional



Operating Expenses Perubahan Tanggal
Adma Biologics USD 80.47M 268K 2024-12
Dynavax Technologies USD 73.66M 3.12M 2024-12
Eli Lilly USD 7.32B 1.06B 2025-03
Halozyme Therapeutics USD 122.51M 4.38M 2024-12
Insmed USD 334.86M 28M 2024-12
MacroGenics USD 35.94M 20.58M 2024-12
MannKind USD 63.68M 11.62M 2024-12
Merck USD 9.66B 1.67B 2025-03
Novo Nordisk DKK 37.49B 4.64B 2024-09
Pfizer USD 10.05B 8.12B 2025-03
Sanofi EUR 8.32B 1.55B 2025-03
Xencor USD 65.97M 7.02M 2024-12



MannKind Biaya Operasional - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - May 2025.